Drug Bought by Startup Jumps to $750

5

DaraprimA drug commonly used to treat life-threatening parasitic infections has jumped in price from $13.50 to $750 per tablet after being acquired by a pharmaceutical startup run by a former hedge fund manager.

The 62-year-old drug, Daraprim, was acquired by Turing Pharmaceuticals earlier this year. It’s price jump is one of a series of increases for everything from Hepatitis drugs to generics after acquisition by companies that rebrand them by “specialty drugs,” the New York Times reports.

Physicians worry that the increase may lead doctors to prescribe less costly but less effective remedies. Read more at The New York Times.

{Andy Heller-Matzav.com Newscenter}

5 COMMENTS

  1. “has jumped in price from $13.50 to $750 per tablet after being acquired by a pharmaceutical startup run by a former hedge fund manager.”

    That says it all. Just another scam run by a “former” hedge fund manager. Haven’t they done enough damage to the American economy with the lower income crowd always getting hit the hardest? Why is the FDA silent about this?

  2. some antibiotics run for several thousand a prescriotion which causes patiens to go without them or to seek alternative remedies.
    vankomaycin (used to treat mrsa) costs about 2000 in capsule form, the IV version is quite cheap. this proves that the actual active ingredient of drug itself is not so pricy

  3. If it treats “life threatening” parasites, why not boost its price to $75,000? This story, if true, is horrific – this company is literally making people choose between their money or their lives. Just wondering – how much is a pill to treat life-threatening parasitic companies?

LEAVE A REPLY

Please enter your comment!
Please enter your name here